Shuichi Hironaka, MD, PhD | Authors


Phase I/II Study Demonstrates Good Efficacy for Gastric Cancer

April 23, 2020

Shuichi Hironaka, MD, PhD, discusses the efficacy of a phase I/II study of nivolumab, paclitaxel, and ramucirumab as second-line treatment of patients with advanced gastric cancer during the 2020 Gastrointestinal Cancers Symposium.